Theonys
About:
Theonys is harnessing the power of tRNA to pioneer an entirely new class of genomic medicines.
Website: http://www.theonys.com/
Twitter/X: Theonys_is_tRNA
Description:
Theonys is a patient-focused drug discovery company that's harnessing the power of tRNA to pioneer an entirely new class of genomic medicines.
Total Funding Amount:
$13.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)theonys.com
Founders:
Nick Davis
Number of Employees:
11-50
Last Funding Date:
2022-08-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai